<DOC>
	<DOCNO>NCT00913523</DOCNO>
	<brief_summary>Subjects use investigational control tampon menstrual period tampon intend prevent , treat diagnose infection disease condition . A total 450 woman participate study two study site . Subjects randomly assign one three tampon group . The first group test experimental test tampon contain glycerol monolaurate ( GML ) cover . The second group test identical tampon , without GML . The third group issue study tampon instruct use normal tampon brand . This study intend determine whether effect GML observe laboratory demonstrate healthy menstruate woman .</brief_summary>
	<brief_title>Clinical Evaluation Effects Investigational Tampon Vaginal Microflora</brief_title>
	<detailed_description>Subjects use investigational control tampon menstrual period tampon intend prevent , treat diagnose infection disease condition . This study randomize , single-blinded , multi-center study woman use Tampons GML , Tampons without GML Tampons Normally Used one menstrual period . Subjects undergo Baseline microflora evaluation take vaginal wall 5-10 day follow menstrual period ( Baseline evaluation ) . Subjects randomly assign use one three study product next menstrual period . Microflora re-evaluated sample take tampon vaginal wall use study tampon , vaginal wall soon end menstrual period . Evaluations microflora do quantitative culture tampon vaginal swab , also Nugent score vaginal swab . Staphylococcal Î±-hemolysin TSST-1 analyze extract study tampon subject find colonize S. aureus . Vaginal pH measure , use electronic meter , clinic visit . All sample ( tampon vaginal swab ) analyze central microbiology laboratory . Extracts tampon find contain S. aureus forward another central laboratory toxin assay . Personnel central laboratory blind group assignment ( study product ) subject completion study .</detailed_description>
	<mesh_term>Monolaurin</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>normal healthy woman 1845 year age regular 21 35day menstrual cycle least 5 day bleed , least 3 day bleed use hormonal contraception use tampon principal mode menstrual sanitary protection least previous 6 month willing change feminine care hygiene practice participation study ( except direct protocol instruction participant ) sign symptom clinically significant vulvovaginal infection vaginosis history recurrent urinary tract vulvovaginal infection abnormal vaginal discharge etiology use systemic , vaginal , perineal antibiotic , antifungal , antiinfective , immunosuppressant medication experimental drug medical device within 30 day precede Screening/Baseline Visit history treatment Toxic Shock Syndrome ( TSS ) suspicion TSS clinical issue history ( per protocol ) would make participation trial inappropriate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>tampon</keyword>
	<keyword>Glycerol Monolaurate</keyword>
	<keyword>vaginal microflora</keyword>
	<keyword>microbe</keyword>
	<keyword>Vaginal Tampon</keyword>
</DOC>